Alzheimer's disease

Lilly’s adcomm win shows amyloid and tau will likely dominate Alzheimer’s — for now
Pharma Voice
Thu, 06/13/24 - 10:50 am
Eli Lilly
Alzheimer's disease
donanemab
amyloid
tau
Alzheimer’s Drug Developer Alzheon Closes $100M Series E Financing
Genetic Engineering News
Wed, 06/12/24 - 11:29 pm
Alzheon
clinical trials
funding
Alzheimer's disease
valiltramiprosate
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive
Mon, 06/10/24 - 06:09 pm
Eli Lilly
FDA
donanemab
Alzheimer's disease
FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date
Fierce Pharma
Mon, 06/10/24 - 11:19 am
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease
FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Reuters
Thu, 06/6/24 - 09:11 pm
Eli Lilly
FDA
Alzheimer's disease
donanemab
FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety
Fierce Biotech
Thu, 06/6/24 - 11:45 am
Eli Lilly
donanemab
FDA
Alzheimer's disease
Lucy Therapeutics secures $12.5m for neurological treatment development
Pharmaceutical Business Review
Wed, 05/29/24 - 11:49 am
Lucy Therapeutics
funding
Alzheimer's disease
Parkinson's Disease
Otsuka Drops Alzheimer’s Agitation Drug Following Phase III Failure
BioSpace
Wed, 05/22/24 - 11:20 am
Otsuka
Alzheimer's disease
Alzheimer's agitation
clinical trials
AVP-786
Voyager doses first patient with anti-tau antibody in Alzheimer’s trial
Clinical Trials Arena
Mon, 05/20/24 - 11:05 am
Voyager Therapeutics
Alzheimer's disease
clinical trials
VY-TAU01
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
Reuters
Tue, 05/14/24 - 11:03 pm
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease
Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot
Pharmaphorum
Mon, 05/13/24 - 11:13 am
Takeda
AC Immune
Alzheimer's disease
ACI-24.060
Acumen doses first patient in Phase II Alzheimer’s disease trial
Clinical Trials Arena
Thu, 05/9/24 - 07:16 pm
Acumen Pharmaceuticals
clinical trials
sabirnetug
Alzheimer's disease
Lilly gets a date with FDA to discuss Alzheimer's med donanemab
Fierce Biotech
Tue, 05/7/24 - 11:21 am
Eli Lilly
FDA
advisory committees
Alzheimer's disease
donanemab
Eli Lilly Gears Up for Donanemab Adcomm as FDA Ponders Changes to Format
BioSpace
Mon, 05/6/24 - 11:43 am
Eli Lilly
FDA
donanemab
advisory committees
Alzheimer's disease
Alzheimer's drug adoption in US slowed by doctors' skepticism
Reuters
Tue, 04/23/24 - 09:47 pm
Eisai
Biogen
Leqembi
physicians
Alzheimer's disease
Eisai hunts for next Alzheimer’s drug with new research pact
BioPharma Dive
Mon, 04/22/24 - 05:49 pm
Eisai
R&D
Alzheimer's disease
BioArctic
Roche’s Early Alzheimer’s Blood Test Gets FDA Breakthrough Device Designation
Xtalks
Thu, 04/18/24 - 10:28 pm
Roche
FDA
Medtech
Eli Lilly
Elecsys pTau217
Alzheimer's disease
diagnostics
Lilly Alzheimer's med glides out of Leqembi's slipstream with FDA adcomm request
Fierce Biotech
Wed, 04/17/24 - 09:58 pm
Eli Lilly
donanemab
Alzheimer's disease
Leqembi
Biogen
Eisai
FDA
FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test
Pharmaphorum
Thu, 04/11/24 - 10:52 am
diagnostics
Roche
Eli Lilly
Alzheimer's disease
FDA
breakthrough designation
A dementia-focused VC digs past amyloid for new kinds of brain drugs
BioPharma Dive
Wed, 04/3/24 - 11:21 am
funding
venture capital
dementia
Dementia Discovery Fund
Alzheimer's disease

Pages